Literature DB >> 29114124

Seroprevalence and molecular evaluation of toxoplasmosis in children with cancer in Khuzestan province, Southwest of Iran.

Jasem Saki1,2, Sanaz Tavakoli2, Mohammad Pedram3.   

Abstract

Toxoplasma gondii is an intracellular parasite with global distribution. Toxoplasmosis in individuals with normal immune system is usually asymptomatic, but in immunocompromised patients may lead to death if not cured. In this study, the prevalence rate of acute and chronic toxoplasmosis in children with cancer was investigated using serological and molecular methods. Blood samples were taken from 372 children with cancer in Shafa hospital in Ahvaz, southwest of Iran. Anti-T. gondii IgG and IgM antibodies were investigated by ELISA. The presence of Toxoplasma in the blood samples was evaluated by Nested PCR. Among 372 children with cancer, 155 (41.7%) were positive for anti-T. gondii IgG antibodies and 24 (6.4%) were positive for anti-T. gondii IgM antibodies, as well. In IgG avidity test, 34 (22%) had antibodies indicating acute phase and 121 (78%) had antibodies indicating chronic phase. The Nested PCR results were showed T. gondii parasite in 34 (100%) patients among 34 IgG antibody-positive patients with acute infection, among 16 IgG antibody-positive patients with chronic infection, 10 patients were indicative of T. gondii and 6 patients were not indicative of T. gondii. A total of 50 cases, 44 (88%) were T. gondii-positive and 6 (12%) were T. gondii-negative in Nested PCR. This study showed high prevalence of toxoplasmosis in children with cancer. Results of serological techniques (ELISA and IgG avidity) had a higher overlap with Nested PCR in identifying T. gondii of seropositive patients.

Entities:  

Keywords:  Cancer; Iran; PCR; Seroprevalence; Toxoplasma gondii

Year:  2017        PMID: 29114124      PMCID: PMC5660016          DOI: 10.1007/s12639-017-0916-4

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  33 in total

1.  Lack of utility of specific immunoglobulin G antibody avidity for serodiagnosis of reactivated toxoplasmosis in immunocompromised patients.

Authors:  B Mechain; Y J Garin; F Robert-Gangneux; J Dupouy-Camet; F Derouin
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

Review 2.  Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis.

Authors:  A L Sutterland; G Fond; A Kuin; M W J Koeter; R Lutter; T van Gool; R Yolken; A Szoke; M Leboyer; L de Haan
Journal:  Acta Psychiatr Scand       Date:  2015-04-15       Impact factor: 6.392

3.  Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis.

Authors:  M H Bessières; A Berrebi; S Cassaing; J Fillaux; J P Cambus; A Berry; C Assouline; J M Ayoubi; J F Magnaval
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

4.  Toxoplasmosis in patients with cancer.

Authors:  D M Israelski; J S Remington
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

5.  Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory.

Authors:  O Liesenfeld; J G Montoya; S Kinney; C Press; J S Remington
Journal:  J Infect Dis       Date:  2001-03-16       Impact factor: 5.226

Review 6.  Toxoplasmosis in Blood Donors: A Systematic Review and Meta-Analysis.

Authors:  Masoud Foroutan-Rad; Hamidreza Majidiani; Sahar Dalvand; Ahmad Daryani; Wesam Kooti; Jasem Saki; Faezeh Hedayati-Rad; Ehsan Ahmadpour
Journal:  Transfus Med Rev       Date:  2016-03-30

7.  Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction.

Authors:  J L Burg; C M Grover; P Pouletty; J C Boothroyd
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

8.  Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis.

Authors:  J K Frenkel; A Escajadillo
Journal:  Am J Trop Med Hyg       Date:  1987-05       Impact factor: 2.345

9.  Design of Indigenous ELISA Using Tachyzoites from the RH Strain of Toxoplasma gondii and Comparison with Commercial Kits in Ahvaz, Southwest of Iran, 2015.

Authors:  Niloofar Mohammadpour; Jasem Saki; Abdollah Rafiei; Ali Khodadadi; Mehdi Tavalla; Bahman Cheraghian
Journal:  Jundishapur J Microbiol       Date:  2016-09-13       Impact factor: 0.747

Review 10.  Is chronic toxoplasmosis a risk factor for diabetes mellitus? A systematic review and meta-analysis of case-control studies.

Authors:  Hamidreza Majidiani; Sahar Dalvand; Ahmad Daryani; Ma de la Luz Galvan-Ramirez; Masoud Foroutan-Rad
Journal:  Braz J Infect Dis       Date:  2016-10-18       Impact factor: 3.257

View more
  4 in total

1.  Seroepidemiological evaluation of Toxoplasma gondii immunity among the general population in southwest of Iran.

Authors:  Shahrzad Soltani; Masoud Foroutan; Hamed Afshari; Maryam Hezarian; Mehdi Sagha Kahvaz
Journal:  J Parasit Dis       Date:  2018-10-23

2.  Association between Toxoplasma gondii exposure and paediatrics haematological malignancies: a case-control study.

Authors:  Narges Kalantari; Javad Rezanejad; Ahmad Tamadoni; Salman Ghaffari; Jaber Alipour; Masomeh Bayani
Journal:  Epidemiol Infect       Date:  2018-08-10       Impact factor: 4.434

3.  Toxoplasma gondii Infection Among Institutionalized Children with Down syndrome in Sana'a city, Yemen: Implications of Low IgG Seroprevalence.

Authors:  Asmaa A H Al-Awadi; Rashad Abdul-Ghani; Abdulsalam M Al-Mekhlafi
Journal:  Acta Parasitol       Date:  2021-10-08       Impact factor: 1.534

4.  Seroprevalence and risk factors of Toxoplasma gondii infection in oral cancer patients in China: a case-control prospective study.

Authors:  N Zhou; X Y Zhang; Y X Li; L Wang; L L Wang; W Cong
Journal:  Epidemiol Infect       Date:  2018-07-13       Impact factor: 4.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.